Alantolactone is a Selective STAT3 Inhibitor for Oral Squamous Cell Carcinoma Research
Oral squamous cell carcinoma (OSCC) is one of the most prevalent and fatal oral cancers. Mitochondria-targeting therapies represent promising strategies against various cancers. Alantolactone (ALT) possesses anticancer properties and also…